The Evolution of Risk Assessment in Pulmonary Arterial Hypertension

por Murthy, Sandhya, Benza, Raymond
Publicado 2021

Replacing a phosphodiesterase-5 inhibitor with riociguat in patients with connective tissue disease-associated pulmonary arterial hypertension: a case series

por Raina, Amresh, Benza, Raymond L., Farber, Harrison W.
Publicado 2017

Ethical considerations of thoracic transplant and circulatory support during the COVID-19 pandemic: A closer look at pulmonary vascular disease

por Bradley, Elisa A., Boucly, Athénaïs, Benza, Raymond L.
Publicado 2020

Safety and efficacy of transitioning from the combination of bosentan and sildenafil to alternative therapy in patients with pulmonary arterial hypertension

por Verlinden, Nathan J., Benza, Raymond L., Raina, Amresh
Publicado 2020

Phosphodiesterase type 5 inhibitor to riociguat transition is associated with hemodynamic and symptomatic improvement in pulmonary hypertension

por Davey, Ryan, Benza, Raymond L., Murali, Srinivas, Raina, Amresh
Publicado 2017

Concomitant cat scratch disease and squamous cell carcinoma in a cardiac transplant

por Bhanot, Nitin, Sokos, George G., Benza, Raymond L., Murali, Srinivas
Publicado 2011

Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: State of the art review

por Wesley Milks, Michael, Sahay, Sandeep, Benza, Raymond L., Farber, Harrison W.
Publicado 2021

Risk assessment in patients with functional class II pulmonary arterial hypertension: Comparison of physician gestalt with ESC/ERS and the REVEAL 2.0 risk score

por Sahay, Sandeep, Tonelli, Adriano R., Selej, Mona, Watson, Zachary, Benza, Raymond L.
Publicado 2020

Early intervention in the management of pulmonary arterial hypertension: clinical and economic outcomes

por Burger, Charles D, Ghandour, Mohamedanwar, Padmanabhan Menon, Divya, Helmi, Haytham, Benza, Raymond L
Publicado 2017

Data on clinical and economic burden associated with pulmonary arterial hypertension related hospitalizations in the United States

por Chaturvedi, Abhishek, Kanwar, Manreet, Chandrika, Parul, Thenappan, Thenappan, Raina, Amresh, Benza, Raymond L
Publicado 2020

Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertension

por Raina, Amresh, Coons, James C., Kanwar, Manreet, Murali, Srinivas, Sokos, George, Benza, Raymond L.
Publicado 2013

Association between cytokines and functional, hemodynamic parameters, and clinical outcomes in pulmonary arterial hypertension

por Joshi, Aditya A., Davey, Ryan, Rao, Youlan, Shen, Kai, Benza, Raymond L., Raina, Amresh
Publicado 2018

Safety and efficacy of RT234 vardenafil inhalation powder on exercise parameters in pulmonary arterial hypertension: phase II, dose-escalation study design

por Benza, Raymond L., Franco, Veronica, Aras, Mandar A., Spikes, Leslie, Grinnan, Daniel, Satler, Carol
Publicado 2022

MicroCT analysis of vascular morphometry: a comparison of right lung lobes in the SUGEN/hypoxic rat model of pulmonary arterial hypertension

por Faight, Erin M., Verdelis, Kostas, Zourelias, Lee, Chong, Rong, Benza, Raymond L., Shields, Kelly J.
Publicado 2017

Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

por Humbert, Marc, Farber, Harrison W., Ghofrani, Hossein-Ardeschir, Benza, Raymond L., Busse, Dennis, Meier, Christian, Hoeper, Marius M.
Publicado 2019

Bosentan-based, treat-to-target therapy in patients with pulmonary arterial hypertension: results from the COMPASS-3 study

por Benza, Raymond L., Raina, Amresh, Gupta, Himanshu, Murali, Srinivas, Burden, Annie, Zastrow, Michael S., Park, Myung H., Simon, Marc A.
Publicado 2017

Switching to riociguat: a potential treatment strategy for the management of CTEPH and PAH

por Benza, Raymond L., Corris, Paul A., Ghofrani, Hossein-Ardeschir, Kanwar, Manreet, McLaughlin, Vallerie V., Raina, Amresh, Simonneau, Gérald
Publicado 2020

LGE in pulmonary hypertension predicts clinical events

por Soma, Siva, Murali, Srinivas, Benza, Raymond, Yamrozik, June A, Williams, Ronald B, Doyle, Mark, Vido, Diane, Biederman, Robert WW, Rathi, Vikas
Publicado 2011

RV fibrosis in pulmonary hypertension impact on prognosis; does formal quantitation augment prognosis?

por Soma, Siva Kumar R, Goyal, Vishal, Yamrozik, June, Williams, Ronald B, Doyle, Mark, Murali, Srinivas, Benza, Raymond L, Biederman, Robert W
Publicado 2013

Management of COVID-19 in a durable left ventricular assist device recipient: A continuity of care perspective

por Korada, Sai Krishna C., Mann, James A., Hasan, Ayesha K., Baliga, Ragavendra R., Mokadam, Nahush A., Benza, Raymond L., Vallakati, Ajay
Publicado 2020